1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Global Virus-Like Particles (VLPs) Trends Industry

Global Virus-Like Particles (VLPs) Trends Industry

  • January 2014
  • -
  • Global Industry Analysts
  • -
  • 12 pages

The report analyzes and presents an overview of Virus-Like Particles (VLPs) market worldwide. "Virus-like particles or VLPs bear high structural resemblance to viruses, though completely non-infectious in nature due to the absence of viral genetic material. While lacking the DNA material, VLPs retain key immunological characteristics of viruses including particulate structures; repetitive surfaces; and capability to induce innate immunity by activating molecular-pattern pathogen-associated recognition receptors."

The report also provides a review of types, medium of production, quantification, applications, and advantages of VLPs over conventional vaccines along with strategic industry activities of major companies worldwide. In addition, 10 companies operating in the Direct Attached Storage (DAS) arena worldwide including Cytos Biotechnology AG, Medicago Inc., Novavax Inc., Redbiotec AG, Virometix AG, VLPbio - The Vaccines Company and other are profiled.

Table Of Contents

Global Virus-Like Particles (VLPs) Trends Industry

1.VIRUS-LIKE PARTICLES - A TECHNOLOGY OVERVIEW

Virus-like Particles: An Introduction

Ability to Elicit Immune Response: A Unique Characteristic of VLPs

Virus-like Particles: Types

Mycovirus VLPs

Chimeric VLPs

Empty Virus-like Particles (eVLPs)

Functional Influenza VLPs

Respiratory Syncytial VLPs

Rabies Glycoprotein VLPs

Virus-like Particles: Medium of Production

Insect Cell Lines

Plant Cell Lines

Yeast Cells

Heterologous Expression Systems

Virus-like Particles: Quantification

Virus-like Particles: Applications

Vaccine Development

Treatment of Chronic Diseases

Advantages of VLP-based Vaccines over Conventional Vaccines

Comparison with Recombinant Protein Vaccines

Comparison with Chicken Egg-based Vaccines

Advantage of Using VLPs in Development of Flu Vaccine

Use of VLPs in Nanotechnology for Targeted Drug Delivery

2.NOTEWORTHY INDUSTRY ACTIVITY

Medicago and a Leading Pharmaceutical Company Ink Loan Agreement

Medicago Develops New VLP-based Vaccine Candidate againstH7N9 Virus

Novavax Commences Animal Studies on H7N9 VLP Vaccine

Medicago to Increase Production Capacity of Pilot Facility

Medicago Completes Preclinical Studies on New VLP Vaccine Candidate against Rabies

Novavax Concludes Phase I Clinical Trials on A/H5N1 Vaccine Candidate

Medicago and USAMRIID Ink Research Collaboration Agreement

Novavax Secures Contract from Biomedical Advanced Research and Development Authority

Medicago and PT Bio Farma Ink Memorandum of Understanding

Medicago Files Patent Applications for New VLP/Recombinant Proteins Production Methods

Novavax Receives US Patent for Influenza VLP Vaccine Technology

Novavax Concludes Phase II Clinical Trial on Trivalent Seasonal Influenza VLP-based Vaccine Candidate

3.MARKET PARTICIPANTS

Cytos Biotechnology AG (Switzerland)

Icosagen AS (Estonia)

Medicago, Inc. (Canada)

Medigene AG (Germany)

Novavax, Inc. (USA)

Oxford Expression Technologies Ltd. (UK)

Paragon Bioservices, Inc. (USA)

Redbiotec AG (Switzerland)

Virometix AG (Switzerland)

VLPbio - The Vaccines Company (Spain)

4.APPENDIX



View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Cancer Vaccines: Technologies and Global Markets

Cancer Vaccines: Technologies and Global Markets

  • $ 6650
  • Industry report
  • November 2016
  • by BCC Research

This cancer vaccines report by BCC Research explores present and future strategies within the market which includes prophylactic vaccines and therapeutic vaccines. Use this report to: - Analyze the global ...

Human Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Human Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • October 2016
  • by Transparency Market Research

Human Vaccines Market: Scope and Methodology This report provides in-depth region wise and country wise analysis of the human vaccines market. Stakeholders of this report include manufacturers of human ...

Clostridium Vaccine Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

Clostridium Vaccine Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • November 2016
  • by Transparency Market Research

Global Clostridium Vaccine (Animal Health) Market: Scope of the Report This report on the clostridium vaccine (animal health) market studies the current as well as future prospects of the market globally. ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.